Difference between revisions of "MHENCR"
Jiabao Cao (talk | contribs) (→Expression) |
|||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
| − | |||
==Annotated Information== | ==Annotated Information== | ||
===Name=== | ===Name=== | ||
| Line 5: | Line 4: | ||
===Cellular Localization=== | ===Cellular Localization=== | ||
| − | MHENCR is predominantly localized in the cytoplasm of melanoma cells | + | MHENCR is predominantly localized in the cytoplasm of melanoma cells <ref name="ref1" />. |
===Function=== | ===Function=== | ||
[[File:LncRNA MHENCR function.jpg|right|thumb|400px|'''The effects of MHENCR on melanoma cell proliferation, cell cycle and apoptosis'''<ref name="ref1" />.]] | [[File:LncRNA MHENCR function.jpg|right|thumb|400px|'''The effects of MHENCR on melanoma cell proliferation, cell cycle and apoptosis'''<ref name="ref1" />.]] | ||
| − | + | MHENCR functions as an oncogene in melanoma via activating miR-425/489-mediated PI3K-Akt pathway <ref name="ref1" />. MHENCR knockdown significantly inhibits melanoma cells proliferation, induces cell cycle arrest and apoptosis, and also attenuates melanoma cells migration. | |
| − | MHENCR knockdown significantly inhibits melanoma cells proliferation, induces cell cycle arrest and apoptosis, and also attenuates melanoma cells migration. | + | |
| + | MHENCR as a competitively endogenous RNA, which specifically bound to miR-425 and miR-489, can upregulate their target genes IGF1 and SPIN1 expression, and further activate PI3K-Akt pathway <ref name="ref1" />. | ||
===Expression=== | ===Expression=== | ||
| − | The expression of MHENCR is upregulated in melanoma tissues and further upregulated in later stage and metastatic lesions | + | The expression of MHENCR is upregulated in melanoma tissues and further upregulated in later stage and metastatic lesions, and high expression of MHENCR is associated with poor prognosis of melanoma patients <ref name="ref1" />. |
| − | |||
===Diseases=== | ===Diseases=== | ||
| − | Melanoma<ref name="ref1" /> | + | Melanoma <ref name="ref1" /> |
===Sequence=== | ===Sequence=== | ||
>NR_132417.1 Homo sapiens melanoma highly expressed competing endogenous lncRNA for miR-425 and miR-489 (MHENCR), transcript variant 1, long non-coding RNA | >NR_132417.1 Homo sapiens melanoma highly expressed competing endogenous lncRNA for miR-425 and miR-489 (MHENCR), transcript variant 1, long non-coding RNA | ||
Latest revision as of 08:52, 28 September 2017
Contents
Annotated Information
Name
MHENCR:melanoma highly expressed competing endogenous lncRNA for miR-425 and miR-489
Cellular Localization
MHENCR is predominantly localized in the cytoplasm of melanoma cells [1].
Function
The effects of MHENCR on melanoma cell proliferation, cell cycle and apoptosis[1].
MHENCR functions as an oncogene in melanoma via activating miR-425/489-mediated PI3K-Akt pathway [1]. MHENCR knockdown significantly inhibits melanoma cells proliferation, induces cell cycle arrest and apoptosis, and also attenuates melanoma cells migration.
MHENCR as a competitively endogenous RNA, which specifically bound to miR-425 and miR-489, can upregulate their target genes IGF1 and SPIN1 expression, and further activate PI3K-Akt pathway [1].
Expression
The expression of MHENCR is upregulated in melanoma tissues and further upregulated in later stage and metastatic lesions, and high expression of MHENCR is associated with poor prognosis of melanoma patients [1].
Diseases
Melanoma [1]
Sequence
>NR_132417.1 Homo sapiens melanoma highly expressed competing endogenous lncRNA for miR-425 and miR-489 (MHENCR), transcript variant 1, long non-coding RNA
000001 CAGCTCCTAA CGCCGCAGGT TCCTCCTGGT CCCCGAGGCC CCCGGTCGGG CGTTGCCTGC CCCGCGCGGG CGGCCGGGCC 000080
000081 GAGGGACGAT GGTCAGTGGA CGGACGGCGC CAGGGAGCAG TGCCCACGCG CGGCAGGGCG GTACCTTCAG GCCTCCAGAG 000160
000161 GCTGGGGCTG GCTCTGTTGG CCTCTGTGCT GGGTTTCTTC CTCTGCACCG CAGGACTGGC TCTCCTGACC TCTCCAGGTG 000240
000241 TCATCGAACA CCCTTGTGCT TGCTGTCACC CGCTGCCTGT CTGCAGGATC CCGGATTCCG TATCAGGGGA CCGAAATTAG 000320
000321 TCGGAAAATA GGAAGCAGGT GCTCGCTTGG ATGGAACCCT GACCCTGTGC TCACACTTGT AGGAGGAGGG CTCTGCAGGC 000400
000401 CGCCTCCCGG AACGGGAGGT TCCCAAGCCA CTGCACTTCG GAGGGGCTGT AATTAGAGTT GCACATTCAT TCAGTTCCCA 000480
000481 GTAAAGTAGA ACGTGCTCCA GCCAGTGAGG AAAAGGTGTT TTTAAAAATT AGATTGGCCG AGTGCGGTGG CTCATGCCTT 000560
000561 TTACCTCAAC ACTTTGGGAG ACAAAGGTGG GAGGATCACC TGTGGCCAGG AGTTCAAGAC CAGCCTGGGC AACAGAGCCT 000640
000641 GTCTCTGGGG AAGAATAAAA AAAAAAATTG AGCCTTTGTC AGTGCTACTA TTTTATTATC TGGTAAATAT GAGAGGGTTC 000720
000721 ACGCGGTCTA TGTGTGTCAT TTATCTGAGT TTGCCTATCG TCACGTTTTG GAAATAAATG TCAATAAAGT CGA
000081 GAGGGACGAT GGTCAGTGGA CGGACGGCGC CAGGGAGCAG TGCCCACGCG CGGCAGGGCG GTACCTTCAG GCCTCCAGAG 000160
000161 GCTGGGGCTG GCTCTGTTGG CCTCTGTGCT GGGTTTCTTC CTCTGCACCG CAGGACTGGC TCTCCTGACC TCTCCAGGTG 000240
000241 TCATCGAACA CCCTTGTGCT TGCTGTCACC CGCTGCCTGT CTGCAGGATC CCGGATTCCG TATCAGGGGA CCGAAATTAG 000320
000321 TCGGAAAATA GGAAGCAGGT GCTCGCTTGG ATGGAACCCT GACCCTGTGC TCACACTTGT AGGAGGAGGG CTCTGCAGGC 000400
000401 CGCCTCCCGG AACGGGAGGT TCCCAAGCCA CTGCACTTCG GAGGGGCTGT AATTAGAGTT GCACATTCAT TCAGTTCCCA 000480
000481 GTAAAGTAGA ACGTGCTCCA GCCAGTGAGG AAAAGGTGTT TTTAAAAATT AGATTGGCCG AGTGCGGTGG CTCATGCCTT 000560
000561 TTACCTCAAC ACTTTGGGAG ACAAAGGTGG GAGGATCACC TGTGGCCAGG AGTTCAAGAC CAGCCTGGGC AACAGAGCCT 000640
000641 GTCTCTGGGG AAGAATAAAA AAAAAAATTG AGCCTTTGTC AGTGCTACTA TTTTATTATC TGGTAAATAT GAGAGGGTTC 000720
000721 ACGCGGTCTA TGTGTGTCAT TTATCTGAGT TTGCCTATCG TCACGTTTTG GAAATAAATG TCAATAAAGT CGA
Labs working on this lncRNA
- Department of Burn and Plastic Surgery, The 253rd Hospital of PLA Hohhot, Inner Mongolia, China.
